Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt.
Vasco C RomãoMaria José SantosJoaquim Polido-PereiraCátia DuartePatrícia NeroCláudia MiguelJosé António CostaMiguel BernardesFernando M Pimentel-SantosFilipe BarcelosLúcia CostaJosé António Melo GomesJosé Alberto Pereira da SilvaJaime Cunha BrancoJosé Canas da SilvaJosé António Pereira da SilvaJoão Eurico FonsecaHelena CanhãoPublished in: BioMed research international (2015)
Compared with TNFi, tocilizumab was associated with greater likelihood of achieving DAS28, CDAI, and SDAI remission/LDA and EULAR good response. Boolean remission and EULAR good/moderate response did not differ significantly between groups.